NeuroAge Therapeutics reposted this
Getting ready for the Longevity Global BOS event with Justin Taylor and Christina Peterson, LICSW. Beautiful view from Mintz Boston office. RSVP: https://lnkd.in/gRg8q_JV
Longevity biotech company that creates new drugs to rejuvenate biological brain aging and treat neurodegenerative disorders using our ML aging clock platform.
External link for NeuroAge Therapeutics
San Francisco, CA 94121, US
NeuroAge Therapeutics reposted this
Getting ready for the Longevity Global BOS event with Justin Taylor and Christina Peterson, LICSW. Beautiful view from Mintz Boston office. RSVP: https://lnkd.in/gRg8q_JV
NeuroAge Therapeutics reposted this
This is a landmark study by our friends and colleagues at TruDiagnostic and Yale University. Not peer reviewed yet but highly significant in our efforts to combat aging and its manifestations. Three interventions stand out for their ability to move the clock: metformin, anti-inflammatory drugs (anti-TNF-alpha) and the Mediterranean diet. Congrats to all involved!
We are thrilled to announce our latest groundbreaking research with Yale University. This first-of-its-kind study analyzed the impact of 51 longevity interventions–spanning diet, exercise, pharmacological, and therapeutic modifications–on multiple biological age clocks to identify which are most effective at slowing aging. Why it’s a big deal: 1.) This is the first meta-analysis of its kind. DNA methylation clocks were created to give us a measuring stick for aging that can be used in real time, so we don't have to wait 40+ years to see how interventions help patients. This is the first major head-to-head comparison of these tools. 2.) The study analyzes all the major DNAm clocks and establishes a new classification of “GenX Clocks”, which refer to a new class of explainable biological age clocks that offer more detailed, system-specific insights into how different parts of the body are aging, allowing users to track specific areas like metabolic, immune, or cardiovascular health. Our SymphonyAge and OMICmAge were classified as “GenX”. 3.) The best part? Not only was TruDiagnostic found to be the only company with explainable clocks, but also the results showed that the clocks we use are the most responsive for measuring interventional impact versus all other clocks. The Study: From diet and exercise to advanced medications, this study evaluated how different interventions impact your aging and how the DNAm clocks’s varied. Key Findings: Medications like metformin and anti-inflammatory treatments showed the strongest results for reducing biological age. Lifestyle choices—especially the Mediterranean diet—consistently improved health markers across multiple systems. Senolytic drugs (which target aging cells) were hit or miss, showing some potential but needing further research. Curious to know how you measure up? Try our TruAge biological age test today! Link Here - https://buff.ly/40tBYU9 Groundbreaking Yale and TruDiagnostic Study Compares 51 Interventions to Slow Aging Across Multiple Biological Clocks https://buff.ly/3NJzGZf
NeuroAge Therapeutics reposted this
Excited to be speaking at the Longevity Global Boston event tomorrow (10/30)! Will be chatting about reversing your brain aging alongside Spring Behrouz of Vincere Biosciences. This is a free event with food and drinks. Thanks to Mintz and quadraScope for sponsoring. All are welcome! RSVP: https://lnkd.in/gRg8q_JV
NeuroAge Therapeutics reposted this
Sleep problems in 30s and 40s may add extra years to your brain age. The time to start working on your sleep is now. -Increasing evidence suggests that there is a link between sleep and brain health. -A new study found that sleep quality issues in early middle-age are associated with accelerated brain aging and cognitive problems later in life. -Another study suggests that people who experience disrupted sleep in their 30s and 40s are more likely to have memory and cognitive problems later in life.
NeuroAge Therapeutics reposted this
Past Longevity Global Summit Speakers have had some incredible accomplishments recently: BioAge Labs- IPO'd this year, last year had positive Phase 1B Clinical trial data Arda Therapeutics- Raised a $43M Series A Juvena Therapeutics- Raised a $41M Series A Shift Bioscience- Raised a $16M Seed GlycanAge- Raised a $4.2M Seed Vincere Biosciences- Raised a Seed round (undisclosed amount) Fauna Bio- closed a $494M deal with Eli Lilly for their platform and obesity drugs And I'm sure I'm missing some. We have an incredible lineup again this year with some new hot companies and cutting edge research covering a variety of topics from medicine, to biotech, to policy. Get your tickets here: https://lnkd.in/gpxvebPg cc: Eric Verdin
NeuroAge Therapeutics reposted this
Excited to be speaking at San Francisco Family Office and High Net Worth Annual Conference November 18th. If you have a family office or are an ultra high net worth individual and would like a complimentary ticket to the event, message me.
NeuroAge Therapeutics reposted this
Loneliness Increases Dementia Risk by 31% A large meta-analysis of over 600,000 people shows that experiencing loneliness significantly raises the risk of developing dementia by 31%. Researchers found that loneliness is a key factor in cognitive decline, contributing to conditions like Alzheimer’s disease, regardless of age or sex.
NeuroAge Therapeutics reposted this
I'm so excited and honored to be a fellow at DOC this year! Can't wait to meet all of the ground breakers making longevity and preventative medicine a reality. Big thanks to the organizers and 🥂
🌟 Honoring 17 incredible women who are shaping the future of healthcare! 🌟 We are thrilled to announce the recipients of this year’s DOC Fellows scholarships—an inspiring group of up-and-coming entrepreneurs, scientists, and innovators who are making an impact on the healthcare landscape. These women represent the next generation of leadership in healthcare, and we are so proud to have them as part of the DOC community. Our 2024 DOC Fellows: Laura Towart, Founder/CEO of Vivan Therapeutics Oriana Papin-Zoghbi, Founder/CEO of AOA Diagnostics Rose Davis, Healthtech Advisor Ariel Ganz, Ph.D., Founding Partner at Arben Ventures Marti Hearst, Ph.D., Professor at UC Berkeley School of Information Missy Krasner, Board Advisor to Stealth Startups Gul Dolen, Ph.D., Professor at University of California Deepti Agarwal, M.D., Medical Director, Precision Medical Loewen Cavill, CEO of Amira Monica Plath, Founder of LittleBird Amie Leighton, Co-founder of Allia Sara Reistad-Long, Operator at Calibrate Christin Glorioso, MD PHD, M.D., Ph.D., CEO & Co-founder of NeuroAge Therapeutics Nathalie Molina Niño, President of Known Ally Perlina, Ph.D., CSO of CureMatch, Inc. Noor Siddiqui, CEO/Founder of Orchid Amanda N Henry, VP of Therabody These women are driving innovation, advancing healthtech, and tackling some of the most pressing challenges in healthcare today. Their vision, expertise, and dedication will undoubtedly lead to transformative change. We can’t wait to see what the future holds for each of them and are honored to support their journey through the DOC Fellows program! Heartfelt thanks to our Doc Fellows partners who made all this possible: The StrongHer Collective, Eat Real, and several private donors. Private Medical Eat Real Certified #HealthcareInnovation #WomenInLeadership #DOCFellows #Entrepreneurship #FutureOfHealthcare #HealthcareEntrepreneurs
NeuroAge Therapeutics reposted this
We are pleased to bring you an amazing lineup of speakers this year at Longevity Summit at the Buck Dec 3-4. Do you have you tickets yet? Learn more and get your tickets today: https://lnkd.in/gx8Q8mYT Speakers: Eric Verdin Lorna Harries Steve Horvath Ronjon Nag Mike (Przemyslaw) Sapieha Christin Glorioso, MD PHD Jesse Poganik Janine Sengstack David Furman Madeleine Cule Noah Davidsohn Hanadie Yousef David Barzilai, MD, PhD, MBA, MS, DipABLM (Agingdoc) Charles Nduka Maddalena Adorno Joseph Raffaele, MD Parnian Lak Brenda Eap PhD Jamie Justice, Ph.D. Ashley Webb Janice Darlington
NeuroAge Therapeutics reposted this
Excited to be speaking in Boston Oct. 30th! Hope to see some folks there.
Will you be in the Boston area on October 30th? Join us for a fascinating discussion about brain aging, how to reverse it, and current cutting edge research in the field. There will be food, drink, and time for Q&A and networks. RSVP here: https://lu.ma/nfc9c9j7 We are coordinating with Biomarkers of Aging Consortium to bring you an event you can attend when in town for their conference that weekend. Thank you so much to Mintz for donating the space, and quadraScope for their generous sponsorship and ongoing support! https://lu.ma/nfc9c9j7